title: FDA, CE mark or something else?-Thinking fast and slow.
abstract: There is a robust debate going on among the Medical Device stake-holders whether FDA is better or CE mark or something else. Currently process of obtaining an FDA approval is bogged down by ever-increasing unpredictability, inconsistency, prolonged time, and huge expense but CE mark has its own problems. Historically, the Japanese review process has tended to be the slowest among the big three but recently with the introduction of accelerated review process there has been a significant progress. While the goal of an innovator/manufacturer is to develop, manufacture and market a medical device that addresses an unmet clinical need, the requisite regulatory approval process can be very confusing. Not only there is a whole lot of jargon tossed around by regulatory affair professionals: "substantial equivalence," "PMDA," "CE mark," "Notified body," "510K" and "PMA" but the actual approval process can also be very tardy, inconsistent and expensive.
authors.forename: Sundeep
authors.initials: S
authors.lastname: Mishra
mesh_terms: D018795:Device Approval / Q000331:legislation & jurisprudence*; D004869:Equipment Safety / Q000592:standards*; D006801:Humans; D013673:Technology Assessment, Biomedical / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
keywords: 510 K; CE mark; Device regulation; EC type examination; Harmonization of regulatory approvals; MDA; Notified body; PMA; PMDA; STED; Substantial equivalence